Anti-Human CD85a/LILRB3 Antibody (SAA2377) from ProteoGenix; catalogue ARO-A22786; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-Human CD85a/LILRB3 Antibody (SAA2377) is a highly specific and sensitive tool for the detection of CD85a/LILRB3 protein in human samples. This antibody is produced using advanced biotechnology techniques and has been extensively validated for its performance in various experimental settings.
CD85a, also known as Leukocyte Immunoglobulin-Like Receptor B3 (LILRB3), is a type I transmembrane protein that belongs to the immunoglobulin superfamily. It is primarily expressed on the surface of immune cells, including monocytes, macrophages, and dendritic cells. CD85a/LILRB3 plays a crucial role in regulating immune responses by interacting with its ligands, such as HLA class I molecules and viral proteins.
The Anti-Human CD85a/LILRB3 Antibody (SAA2377) is an essential tool for studying the role of CD85a/LILRB3 in various immune-related processes. It can be used for flow cytometry, immunohistochemistry, and Western blotting applications. This antibody is also suitable for functional studies, such as blocking experiments, to investigate the impact of CD85a/LILRB3 on immune cell activation and function.
In conclusion, the Anti-Human CD85a/LILRB3 Antibody (SAA2377) is a highly reliable and specific tool for studying the role of CD85a/LILRB3 in immune responses. Its versatility and robust performance make it an ideal choice for researchers in the field of immunology and biomedicine. Order now and advance your research with confidence.
ProteoGenix catalogue number ARO-A22786. For research use only.
Target: Leukocyte immunoglobulin-like receptor subfamily B member 3, LIR-3, Leukocyte immunoglobulin-like receptor 3, CD85 antigen-like family member A, Immunoglobulin-like transcript 5, ILT-5, Monocyte inhibitory receptor HL9, CD85a, LILRB3, ILT5, LIR3; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA, Flow Cyt.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
